Zdrowie i gospodarka · 31/03/2005

FDA Cancels Meeting of Cardiovascular and Renal Drugs Advisory Committee

The US Food and Drug Administration (FDA) has cancelled a meeting of the Cardiovascular and Renal Drugs Advisory Committee, originally scheduled for April 5, 2005, after it was announced in the Federal Register on March 9, 2005 (70 FR 11678).